TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Relacorilant + Nab-Paclitaxel in Patients With Recurrent, Platinum-Resistant Ovarian Cancer: A Three-Arm, Randomized, Controlled, Open-Label Phase II Study.

Nicoletta Colombo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.